Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Mangesh D. Godbole, Prafulla M. Sabale & Vijay B. Mathur. (2020) Development of lamivudine liposomes by three-level factorial design approach for optimum entrapment and enhancing tissue targeting. Journal of Microencapsulation 37:6, pages 431-444.
Read now
Read now
Crystal B Spinks, Ahmed S Zidan, Mansoor A Khan, Muhammad J Habib & Patrick J Faustino. (2017) Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations. Clinical Pharmacology: Advances and Applications 9, pages 29-38.
Read now
Read now
Arpan Chudasama, Vineetkumar Patel, Manish Nivsarkar, Kamala Vasu & Chamanlal Shishoo. (2015) Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations. Drug Delivery 22:4, pages 531-540.
Read now
Read now
Ahmed S. Zidan, Crystal B. Spinks, Muhammad J. Habib & Mansoor A. Khan. (2013) Formulation and transport properties of tenofovir loaded liposomes through Caco-2 cell model. Journal of Liposome Research 23:4, pages 318-326.
Read now
Read now
K. Moriyama, C. Otsuka, D. Loakes & K. Negishi. (2001) HIGHLY EFFICIENT RANDOM MUTAGENESIS IN TRANSCRIPTION-REVERSE-TRANSCRIPTION CYCLES BY A HYDROGEN BOND AMBIVALENT NUCLEOSIDE 5′-TRIPHOSPHATE ANALOGUE: POTENTIAL CANDIDATES FOR A SELECTIVE ANTI-RETROVIRAL THERAPY. Nucleosides, Nucleotides & Nucleic Acids 20:8, pages 1473-1483.
Read now
Read now
. (1999) LITERATURE ALERTS. Journal of Microencapsulation 16:3, pages 395-407.
Read now
Read now
Articles from other publishers (33)
Chou-Yi Hsu, Ahmed Mahdi Rheima, Mustafa M. Kadhim, Nada Nadhim Ahmed, Srwa Hashim Mohammed, Fatima Hashim Abbas, Zainab Talib Abed, Zahra Muhammed Mahdi, Zainab Sabri Abbas, Safa K. Hachim, Farah K. Ali, Zaid H Mahmoud & Ehsan Kianfar. (2023) An overview of nanoparticles in drug delivery: Properties and applications. South African Journal of Chemical Engineering 46, pages 233-270.
Crossref
Crossref
Mohammad Saeedi, Fatemeh Mehranfar, Shaghayegh Omidi Omidi, Fatemeh Zahra Ehsani & Omid Pajand Pajand. (2020) Biological Aspects and Clinical Applications of Nanoparticles on Treatment and Prophylaxis of HIV. Iranian Journal of Medical Microbiology 14:6, pages 512-542.
Crossref
Crossref
Rudzani Malabi, Sello Lebohang Manoto, Saturnin Ombinda‐Lemboumba, Malik Maaza & Patience Mthunzi‐Kufa. (2019) Laser‐enhanced drug delivery of antiretroviral drugs into human immunodeficiency virus‐1 infected TZMbl cells. Journal of Biophotonics 12:10.
Crossref
Crossref
Amit Verma, Ankit Jain, Ankita Tiwari, Shivani Saraf, Pritish K. Panda, G. P. Agrawal & Sanjay K. Jain. (2019) Folate Conjugated Double Liposomes Bearing Prednisolone and Methotrexate for Targeting Rheumatoid Arthritis. Pharmaceutical Research 36:8.
Crossref
Crossref
Nily Dan. 2018. Design and Development of New Nanocarriers. Design and Development of New Nanocarriers
1
55
.
Nily Dan. 2017. Nanostructures for Drug Delivery. Nanostructures for Drug Delivery
63
105
.
Maria Antonietta De Luca, Francesco Lai, Francesco Corrias, Pierluigi Caboni, Zisis Bimpisidis, Elias Maccioni, Anna Maria Fadda & Gaetano Di Chiara. (2015) Lactoferrin- and antitransferrin-modified liposomes for brain targeting of the NK3 receptor agonist senktide: Preparation and in vivo evaluation. International Journal of Pharmaceutics 479:1, pages 129-137.
Crossref
Crossref
Sara BrennerEllis Tobin. 2013. The Clinical Nanomedicine Handbook. The Clinical Nanomedicine Handbook
1
84
.
Abhijit A. Date & Christopher J. Destache. (2013) A review of nanotechnological approaches for the prophylaxis of HIV/AIDS. Biomaterials 34:26, pages 6202-6228.
Crossref
Crossref
Michal Richman, Alex Perelman, Asaf Gertler & Shai Rahimipour. (2012) Effective Targeting of Aβ to Macrophages by Sonochemically Prepared Surface-Modified Protein Microspheres. Biomacromolecules 14:1, pages 110-116.
Crossref
Crossref
Mohammed Asmal, James B. Whitney, Corinne Luedemann, Angela Carville, Robert Steen, Norman L. Letvin & Ralf Geiben-Lynn. (2012) In Vivo Anti-HIV Activity of the Heparin-Activated Serine Protease Inhibitor Antithrombin III Encapsulated in Lymph-Targeting Immunoliposomes. PLoS ONE 7:11, pages e48234.
Crossref
Crossref
Ho Lun Wong, Xiao Yu Wu & Reina Bendayan. (2012) Nanotechnological advances for the delivery of CNS therapeutics. Advanced Drug Delivery Reviews 64:7, pages 686-700.
Crossref
Crossref
L. Lesoin, C. Crampon, O. Boutin & E. Badens. (2011) Development of a continuous dense gas process for the production of liposomes. The Journal of Supercritical Fluids 60, pages 51-62.
Crossref
Crossref
John Cannon. 2011. Drug Delivery Systems, Third Edition. Drug Delivery Systems, Third Edition
1
46
.
Lakshmi N Ramana, Swaminathan Sethuraman, Udaykumar Ranga & Uma M Krishnan. (2010) Development of a liposomal nanodelivery system for nevirapine. Journal of Biomedical Science 17:1.
Crossref
Crossref
Ahmed S. Zidan, Crystal Spinks, Joseph Fortunak, Muhammad Habib & Mansoor A. Khan. (2010) Near-Infrared Investigations of Novel Anti-HIV Tenofovir Liposomes. The AAPS Journal 12:2, pages 202-214.
Crossref
Crossref
Umesh Gupta & Narendra K. Jain. (2010) Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting. Advanced Drug Delivery Reviews 62:4-5, pages 478-490.
Crossref
Crossref
Alejandro Sosnik, Diego A. Chiappetta & Ángel M. Carcaboso. (2009) Drug delivery systems in HIV pharmacotherapy: What has been done and the challenges standing ahead. Journal of Controlled Release 138:1, pages 2-15.
Crossref
Crossref
V. Sánchez-López, J.M. Fernández-Romero & A. Gómez-Hens. (2009) Evaluation of liposome populations using a sucrose density gradient centrifugation approach coupled to a continuous flow system. Analytica Chimica Acta 645:1-2, pages 79-85.
Crossref
Crossref
Elizabeth Ojewole, Irene Mackraj, Panjasaram Naidoo & Thirumala Govender. (2008) Exploring the use of novel drug delivery systems for antiretroviral drugs. European Journal of Pharmaceutics and Biopharmaceutics 70:3, pages 697-710.
Crossref
Crossref
Buz Salafsky. 2006. Insect Repellents. Insect Repellents
327
336
.
Marek Langner & Arkadiusz Kozubek. 2006. Nanocarrier Technologies. Nanocarrier Technologies
113
138
.
Agustina Gómez-Hens & Juan Manuel Fernández-Romero. (2005) The role of liposomes in analytical processes. TrAC Trends in Analytical Chemistry 24:1, pages 9-19.
Crossref
Crossref
André Désormeaux & Michel G. Bergeron. 2005. Liposomes. Liposomes
330
351
.
Vasant Ranade & Mannfred Hollinger. 2003. Drug Delivery Systems, Second Edition. Drug Delivery Systems, Second Edition.
Zhong Xu, Johnsamuel Jayaseharan & Roger E. Marchant. (2002) Synthesis and Characterization of Oligomaltose-Grafted Lipids with Application to Liposomes. Journal of Colloid and Interface Science 252:1, pages 57-65.
Crossref
Crossref
Irma A.J.M. Bakker-Woudenberg. (2002) Long-circulating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious foci. International Journal of Antimicrobial Agents 19:4, pages 299-311.
Crossref
Crossref
Jean-François Gagné, André Désormeaux, Sylvie Perron, Michel J Tremblay & Michel G Bergeron. (2002) Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes. Biochimica et Biophysica Acta (BBA) - Biomembranes 1558:2, pages 198-210.
Crossref
Crossref
Marie-Eve Proulx, André Désormeaux, Jean-François Marquis, Martin Olivier & Michel G. Bergeron. (2001) Treatment of Visceral Leishmaniasis with Sterically Stabilized Liposomes Containing Camptothecin. Antimicrobial Agents and Chemotherapy 45:9, pages 2623-2627.
Crossref
Crossref
Julie Bestman-Smith, André Désormeaux, Michel J. Tremblay & Michel G. Bergeron. (2000) Targeting cell-free HIV and virally-infected cells with anti-HLA-DR immunoliposomes containing amphotericin B. AIDS 14:16, pages 2457-2465.
Crossref
Crossref
M Lüscher-Mattii. (2016) Polyanions — A Lost Chance in the Fight against HIV and other Virus Diseases?. Antiviral Chemistry and Chemotherapy 11:4, pages 249-259.
Crossref
Crossref
M Garcı́a, M.A Alsina, F Reig & I Haro. (1999) Liposomes as vehicles for the presentation of a synthetic peptide containing an epitope of hepatitis A virus. Vaccine 18:3-4, pages 276-283.
Crossref
Crossref
Philip R. Wyde. (1999) Chemotherapy of respiratory viruses: prospects and challenges. Drug Resistance Updates 2:4, pages 244-258.
Crossref
Crossref